CTLA4 and type 1 diabetes mellitus: And Ueda et al. (2003) found that a molecule encoded by CTLA4 was vital for negative regulation of the immune system and could enhance the risk of several ADs, such as Graves disease, autoimmune hypothyroidism, and type 1 diabetes mellitus (T1D), which indicated that ADs might share similar pathogenic mechanisms.